Novel screening tool enables earlier diagnosis of IPF

A new screening tool, the zero-burden comorbidity risk score for idiopathic pulmonary fibrosis, led to earlier diagnosis of IPF and improved outcomes of disease-modifying therapies and other interventions, according to published data.
“These results demonstrate the crucial role machine learning/AI can play in diagnosis of rare diseases, and that patterns buried in the medical histories can be effectively exploited to substantially improve patient outcomes,” Ishanu Chattopadhyay, PhD, assistant professor of medicine at the University of Chicago, told Healio.
Chattopadhyay and

A new screening tool, the zero-burden comorbidity risk score for idiopathic pulmonary fibrosis, led to earlier diagnosis of IPF and improved outcomes of disease-modifying therapies and other interventions, according to published data.
“These results demonstrate the crucial role machine learning/AI can play in diagnosis of rare diseases, and that patterns buried in the medical histories can be effectively exploited to substantially improve patient outcomes,” Ishanu Chattopadhyay, PhD, assistant professor of medicine at the University of Chicago, told Healio.
Chattopadhyay and